BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26950901)

  • 1. Effects of unplanned treatment interruptions on HIV treatment failure - results from TAHOD.
    Jiamsakul A; Kerr SJ; Ng OT; Lee MP; Chaiwarith R; Yunihastuti E; Van Nguyen K; Pham TT; Kiertiburanakul S; Ditangco R; Saphonn V; Sim BL; Merati TP; Wong W; Kantipong P; Zhang F; Choi JY; Pujari S; Kamarulzaman A; Oka S; Mustafa M; Ratanasuwan W; Petersen B; Law M; Kumarasamy N;
    Trop Med Int Health; 2016 May; 21(5):662-74. PubMed ID: 26950901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of unstructured antiretroviral treatment interruption and resumption among HIV-positive individuals in Canada.
    Samji H; Taha TE; Moore D; Burchell AN; Cescon A; Cooper C; Raboud JM; Klein MB; Loutfy MR; Machouf N; Tsoukas CM; Montaner JS; Hogg RS;
    HIV Med; 2015 Feb; 16(2):76-87. PubMed ID: 25174373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for unstructured treatment interruptions and association with survival in low to middle income countries.
    McMahon JH; Spelman T; Ford N; Greig J; Mesic A; Ssonko C; Casas EC; O'Brien DP
    AIDS Res Ther; 2016; 13():25. PubMed ID: 27408611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death.
    Holkmann Olsen C; Mocroft A; Kirk O; Vella S; Blaxhult A; Clumeck N; Fisher M; Katlama C; Phillips AN; Lundgren JD;
    HIV Med; 2007 Mar; 8(2):96-104. PubMed ID: 17352766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of age-associated comorbidities on responses to combination antiretroviral therapy in older people living with HIV.
    Ahn MY; Jiamsakul A; Khusuwan S; Khol V; Pham TT; Chaiwarith R; Avihingsanon A; Kumarasamy N; Wong WW; Kiertiburanakul S; Pujari S; Nguyen KV; Lee MP; Kamarulzaman A; Zhang F; Ditangco R; Merati TP; Yunihastuti E; Ng OT; Sim BLH; Tanuma J; Ratanasuwan W; Ross J; Choi JY;
    J Int AIDS Soc; 2019 Feb; 22(2):e25228. PubMed ID: 30803162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV and aging: insights from the Asia Pacific HIV Observational Database (APHOD).
    Han N; Wright ST; O'Connor CC; Hoy J; Ponnampalavanar S; Grotowski M; Zhao HX; Kamarulzaman A; ;
    HIV Med; 2015 Mar; 16(3):152-60. PubMed ID: 25407085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interruptions of antiretroviral therapy in children and adolescents with HIV infection in clinical practice: a retrospective cohort study in the USA.
    Rakhmanina N; Lam KS; Hern J; Young HA; Walters A; Castel AD
    J Int AIDS Soc; 2016; 19(1):20936. PubMed ID: 27797320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral treatment interruptions induced by the Kenyan postelection crisis are associated with virological failure.
    Mann M; Diero L; Kemboi E; Mambo F; Rono M; Injera W; Delong A; Schreier L; Kaloustian KW; Sidle J; Buziba N; Kantor R
    J Acquir Immune Defic Syndr; 2013 Oct; 64(2):220-224. PubMed ID: 24047971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunovirologic consequences and safety of short, non-structured interruptions of successful antiretroviral treatment.
    Sanchez R; Portilla J; Gimeno A; Boix V; Llopis C; Sanchez-Paya J; Merino E; de la Sen ML; Muñoz C; Reus S; Plazas J
    J Infect; 2007 Feb; 54(2):159-66. PubMed ID: 16690132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term and long-term clinical and immunological consequences of stopping antiretroviral therapy in HIV-infected patients with preserved immune function.
    Imaz A; Olmo M; Peñaranda M; Gutiérrez F; Romeu J; Larrousse M; Domingo P; Oteo JA; Curto J; Vilallonga C; Masiá M; López-Aldeguer J; Iribarren JA; Podzamczer D;
    Antivir Ther; 2013; 18(1):125-30. PubMed ID: 22805174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of HIV-1 Subtype on the Time to CD4+ T-Cell Recovery in Combination Antiretroviral Therapy (cART)-Experienced Patients.
    Chow WZ; Lim SH; Ong LY; Yong YK; Takebe Y; Kamarulzaman A; Tee KK
    PLoS One; 2015; 10(9):e0137281. PubMed ID: 26335136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
    Panel de expertos de GESIDA y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 genotype after interruption of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy and virological response after resumption of the same regimen.
    Sungkanuparph S; Kiertiburanakul S; Apisarnthanarak A; Malathum K; Sathapatayavongs B
    Int J STD AIDS; 2007 Dec; 18(12):832-4. PubMed ID: 18073016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-medically supervised treatment interruptions among participants in a universally accessible antiretroviral therapy programme.
    Moore DM; Zhang W; Yip B; Genebat M; Lima VD; Montaner JS; Hogg RS
    HIV Med; 2010 May; 11(5):299-307. PubMed ID: 20002777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of transient HIV type-1 viraemia and treatment interruptions during suppressive antiretroviral treatment.
    Zhang S; van Sighem A; Gras L; Reiss P; Smit C; Kroon F; Jurriaans S; Prins J; Lange J; de Wolf F
    Antivir Ther; 2010; 15(4):555-62. PubMed ID: 20587848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deferred modification of antiretroviral regimen following documented treatment failure in Asia: results from the TREAT Asia HIV Observational Database (TAHOD).
    Zhou J; Li PC; Kumarasamy N; Boyd M; Chen YM; Sirisanthana T; Sungkanuparph S; Oka S; Tau G; Phanuphak P; Saphonn V; Zhang FJ; Omar SF; Lee CK; Ditangco R; Merati TP; Lim PL; Choi JY; Law MG; Pujari S;
    HIV Med; 2010 Jan; 11(1):31-9. PubMed ID: 19601993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A high HIV DNA level in PBMCs at antiretroviral treatment interruption predicts a shorter time to treatment resumption, independently of the CD4 nadir.
    Piketty C; Weiss L; Assoumou L; Burgard M; Mélard A; Ragnaud JM; Bentata M; Girard PM; Rouzioux C; Costagliola D;
    J Med Virol; 2010 Nov; 82(11):1819-28. PubMed ID: 20872707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4 recovery following antiretroviral treatment interruptions in children and adolescents with HIV infection in Europe and Thailand.
    European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) Study Group in EuroCoord
    HIV Med; 2019 Aug; 20(7):456-472. PubMed ID: 31099155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and predictors of virologic failure of antiretroviral triple-drug therapy in a community-based cohort.
    Paris D; Ledergerber B; Weber R; Jost J; Flepp M; Opravil M; Ruef C; Zimmerli S
    AIDS Res Hum Retroviruses; 1999 Dec; 15(18):1631-8. PubMed ID: 10606086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of HIV-1 genotype in plasma RNA and peripheral blood mononuclear cells proviral DNA after interruption and resumption of antiretroviral therapy.
    Imaz A; Olmo M; Peñaranda M; Gutiérrez F; Romeu J; Larrousse M; Domingo P; Oteo JA; Niubó J; Curto J; Vilallonga C; Masiá M; López-Aldeguer J; Iribarren JA; Podzamczer D;
    Antivir Ther; 2012; 17(3):577-83. PubMed ID: 22301439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.